Duration: 90 Minutes
Regulatory agencies such as US FDA and others expect pharmaceutical companies to treat their suppliers and contractors as an extension of their own operation. Hence oversight of their vendors’ quality compliance is of paramount importance.
A robust, but pragmatic and effective vendor qualification program must be established by the manufacturer of drugs, biologics, medical device, & combination products. This will also apply to the vendors and contractors who have the responsibilities of oversight over their own suppliers and contractors.
Supply chain is becoming increasingly complex due to changing business & regulatory environment in the recent time. Importance of robust due diligence via effective audits of the supply chain is being emphasized by the regulatory agencies around world. Hence, setting up on effective and pragmatic vendor qualification program has become a big challenge to the industry.
Attendees will learn how they can establish such a robust, risk based vendor qualification program in a cost effective manner, but in compliance with the applicable regulatory requirements.
Areas Covered in the Session :
Who Should Attend: